517 related articles for article (PubMed ID: 29927961)
1. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
[TBL] [Abstract][Full Text] [Related]
2. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
3. Adolescent pregnancy at antiretroviral therapy (ART) initiation: a critical barrier to retention on ART.
Nuwagaba-Biribonwoha H; Kiragga AN; Yiannoutsos CT; Musick BS; Wools-Kaloustian KK; Ayaya S; Wolf H; Lugina E; Ssali J; Abrams EJ; Elul B;
J Int AIDS Soc; 2018 Sep; 21(9):e25178. PubMed ID: 30225908
[TBL] [Abstract][Full Text] [Related]
4. Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study.
Kiwanuka G; Kiwanuka N; Muneza F; Nabirye J; Oporia F; Odikro MA; Castelnuovo B; Wanyenze RK
BMC Infect Dis; 2018 Oct; 18(1):533. PubMed ID: 30355356
[TBL] [Abstract][Full Text] [Related]
5. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
[TBL] [Abstract][Full Text] [Related]
6. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015.
Makurumidze R; Mutasa-Apollo T; Decroo T; Choto RC; Takarinda KC; Dzangare J; Lynen L; Van Damme W; Hakim J; Magure T; Mugurungi O; Rusakaniko S
PLoS One; 2020; 15(1):e0222309. PubMed ID: 31910445
[TBL] [Abstract][Full Text] [Related]
7. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study.
Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R
BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
Alvarez-Uria G; Naik PK; Pakam R; Midde M
Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
[TBL] [Abstract][Full Text] [Related]
10. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
[TBL] [Abstract][Full Text] [Related]
11. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
[TBL] [Abstract][Full Text] [Related]
12. High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique.
Molfino L; Kumar AM; Isaakidis P; Van den Bergh R; Khogali M; Hinderaker SG; Magaia A; Lobo S; Edwards CG; Walter J
Glob Health Action; 2014; 7():23758. PubMed ID: 24717189
[TBL] [Abstract][Full Text] [Related]
13. Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.
Makurumidze R; Buyze J; Decroo T; Lynen L; de Rooij M; Mataranyika T; Sithole N; Takarinda KC; Apollo T; Hakim J; Van Damme W; Rusakaniko S
PLoS One; 2020; 15(10):e0240865. PubMed ID: 33075094
[TBL] [Abstract][Full Text] [Related]
14. Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda.
Kamacooko O; Mayanja Y; Bagiire D; Namale G; Hansen CH; Seeley J
BMC Public Health; 2020 Mar; 20(1):353. PubMed ID: 32183759
[TBL] [Abstract][Full Text] [Related]
15. Implementation and Operational Research: Evaluation of Swaziland's Hub-and-Spoke Model for Decentralizing Access to Antiretroviral Therapy Services.
Auld AF; Kamiru H; Azih C; Baughman AL; Nuwagaba-Biribonwoha H; Ehrenkranz P; Agolory S; Sahabo R; Ellerbrock TV; Okello V; Bicego G
J Acquir Immune Defic Syndr; 2015 May; 69(1):e1-12. PubMed ID: 25942465
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
[TBL] [Abstract][Full Text] [Related]
17. Temporal Trends in Patient Characteristics and Outcomes Among Children Enrolled in Mozambique's National Antiretroviral Therapy Program.
Auld AF; Alfredo C; Macassa E; Jobarteh K; Shiraishi RW; Rivadeneira ED; Houston J; Spira TJ; Ellerbrock TV; Vaz P
Pediatr Infect Dis J; 2015 Aug; 34(8):e191-9. PubMed ID: 25955836
[TBL] [Abstract][Full Text] [Related]
18. Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.
Kiwuwa-Muyingo S; Abongomera G; Mambule I; Senjovu D; Katabira E; Kityo C; Gibb DM; Ford D; Seeley J
Int Health; 2020 Sep; 12(5):429-443. PubMed ID: 31730168
[TBL] [Abstract][Full Text] [Related]
19. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
[TBL] [Abstract][Full Text] [Related]
20. Decentralizing Access to Antiretroviral Therapy for Children Living with HIV in Swaziland.
Auld AF; Nuwagaba-Biribonwoha H; Azih C; Kamiru H; Baughman AL; Agolory S; Abrams E; Ellerbrock TV; Okello V; Bicego G; Ehrenkranz P
Pediatr Infect Dis J; 2016 Aug; 35(8):886-93. PubMed ID: 26849157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
